CHARLESTON, S.C.--(BUSINESS WIRE)--Plasma Technologies LLC (PlasmaTech), a plasma biologics technology company, announced that its novel human plasma fractionation process has been shown to achieve a ...
The starting material for virtually all pharmaceuticals and biologics is a synthetic or chemical. Human plasma-derived therapies are one of the few exceptions. A number of fragile proteins can be ...
very day, thousands of Indonesians donate blood and plasma, often unaware of the complex scientific and safety-driven processes that transform a single donation into life-saving therapies. As ...
Dublin, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The "Plasma Fractionation Market Industry Trends and Global Forecasts to 2035, by Type of Company, Scale of Operation, Type of Plasma-derived Therapeutic ...
IRVING, Texas--(BUSINESS WIRE)--Fluor Corporation (NYSE: FLR) announced today that Grifols’ North Fractionation Facility in Clayton, N.C., was named the International Society for Pharmaceutical ...
Ottawa, Oct. 30, 2025 (GLOBE NEWSWIRE) -- The global plasma fractionation market size was valued at USD 35.22 billion in 2024 and is predicted to hit around USD 72.86 billion by 2034, rising at a 7.54 ...
The Netherlands-based Sanquin Blood Supply Foundation (Stichting Sanquin Bloedvoorziening) inked an agreement to provide Baxter with up to 1.6 million liters of plasma fractionation capacity annually, ...
- Grifols makes a significant investment to become the only large-scale commercial manufacturer of plasma products in Canada, with a fractionation capacity of 1.5 million liters/year - The operation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results